Gastric Cancer
📧 Sign up to get email alerts when something new happens for Gastric Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2021-04-06Clinical Trial Update: Pembrolizumab, Trastuzumab, HER2 Positive Gastric Cancer [Phase 1, Phase 2]
Phase 1/2 clinical trial update investigating pembrolizumab and trastuzumab for HER2-positive gastric cancer.
-
CLINICAL_TRIALS trial_result · 2021-04-01Clinical Trial Update: Study of DP303c Injection in Patients With Advanced or Metastatic Gastric Cancer [Phase 2]
Phase 2 clinical trial update for DP303c Injection in advanced or metastatic gastric cancer.
-
CLINICAL_TRIALS trial_result · 2021-03-29Clinical Trial Update: Personalized Targeted IMMUNOtherapy-based Regimens in Recurrent GASTric Adenocarcinoma (IMMUNOGAST) [Phase 2]
Phase 2 trial update on personalized immunotherapy-based regimens for recurrent gastric cancer is in early stages with status currently unkn…
-
CLINICAL_TRIALS trial_result · 2021-03-25Clinical Trial Update: Confocal Endoscopic Microscopy for Detection of Early Stage Gastric Cancer in Subjects With Hereditary Diffuse Gastric Cancer Syndrome [Phase 2]
Phase 2 clinical trial assessing confocal endoscopic microscopy to detect early-stage gastric cancer in individuals with hereditary diffuse …
-
CLINICAL_TRIALS trial_result · 2021-03-17Clinical Trial Update: Efficacy and Safety of Toripalimab Combined With Docetaxel or Nab-paclitaxel in Patients With Advanced Gastric Cancer [Phase 2]
Phase 2 trial update evaluating toripalimab with docetaxel or nab-paclitaxel in advanced gastric cancer.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2021-03-15Clinical Trial Update: A Phase II Study of Conversion Surgery After IP Paclitaxel With XELOX Chemotherapy in AGC With Peritoneal Dissemination [Phase 2]
Phase II study evaluating conversion surgery after intraperitoneal paclitaxel with XELOX in advanced gastric cancer with peritoneal dissemin…
-
CLINICAL_TRIALS trial_result · 2021-03-11Clinical Trial Update: Camrelizumab Combined With SOX and/or Apatinib for Locally Advanced Gastric Cancer [Phase 2]
Phase 2 clinical trial update investigating camrelizumab combined with SOX and/or apatinib for locally advanced gastric cancer.
-
CLINICAL_TRIALS research · 2021-03-10Clinical Trial Update: Effect of Multi-Media Tool on Enrollment in Oncology Clinical Trials
A completed clinical trial evaluating how a multi-media tool affects enrollment in oncology trials; results posted in 2021.
-
CLINICAL_TRIALS trial_result · 2021-03-04Clinical Trial Update: Tislelizumab Plus Anlotinib for Immunotherapy Resistant Gastrointestinal Cancer [Phase 2]
Phase 2 trial update on tislelizumab plus anlotinib for immunotherapy-resistant gastric and colorectal cancer.
-
CLINICAL_TRIALS trial_result · 2021-03-04Clinical Trial Update: Nab-PTX Plus S-1 and Sintilimab as Adjuvant Therapy in Patients With Stage IIIC Gastric Cancer [Phase 1, Phase 2]
Phase 1/2 trial investigating Nab-PTX plus S-1 and Sintilimab as adjuvant therapy for Stage IIIC gastric cancer.
-
CLINICAL_TRIALS trial_result · 2021-02-26Clinical Trial Update: Receiving Modified Chemotherapy Followed With Radical Resection After Neoadjuvant Chemotherapy [Phase 2]
Phase 2 trial updating on receiving modified chemotherapy followed by radical resection after neoadjuvant chemotherapy for locally advanced …
-
CLINICAL_TRIALS trial_result · 2021-02-23Clinical Trial Update: Surgery With or Without Combination Chemotherapy in Treating Patients With Cancer of the Esophagus [Phase 3]
Phase 3 trial update evaluating surgery with or without combination chemotherapy in esophageal and gastric cancer.
-
CLINICAL_TRIALS trial_result · 2021-02-18Clinical Trial Update: Toripalimab Combined With FLOT Neoadjuvant Chemotherapy in Patients With Resectable Gastric Cancer [Phase 2]
Phase 2 trial update evaluating toripalimab in combination with FLOT neoadjuvant chemotherapy for resectable gastric cancer.
-
CLINICAL_TRIALS trial_result · 2021-02-16Clinical Trial Update: Chemotherapy for Patients With Cancer of the Stomach [Phase 1]
Phase 1 trial update for chemotherapy in first-line treatment of non-resectable gastric cancer or cancer of the esophagus; results posted.
-
CLINICAL_TRIALS trial_result · 2021-02-04Clinical Trial Update: Autologous CAR-T/TCR-T Cell Immunotherapy for Solid Malignancies [Phase 1, Phase 2]
Clinical trial update on autologous CAR-T/TCR-T cell therapy for solid malignancies across Phase 1 and Phase 2.
-
CLINICAL_TRIALS trial_result · 2021-02-01Clinical Trial Update: Raltitrexed and Paclitaxel for Gastric or Gastroesophageal Junction Adenocarcinoma [Phase 2]
Phase 2 trial evaluating raltitrexed with paclitaxel for gastric cancer and gastroesophageal junction adenocarcinoma has completed.
-
CLINICAL_TRIALS trial_result · 2021-01-27Clinical Trial Update: Docetaxel, Oxaliplatin, Capecitabine, Bevacizumab and Trastuzumab in Patients With Locally Advanced or Metastatic Gastric Cancer [Phase 2]
Phase 2 trial evaluating a combination of docetaxel, oxaliplatin, capecitabine, bevacizumab, and trastuzumab in locally advanced or metastat…
-
CLINICAL_TRIALS trial_result · 2021-01-20Clinical Trial Update: Oxaliplatin Combined With S-1(SOX) Neoadjuvant Chemotherapy for Different Cycles in Patients With Gastric Cancer [Phase 3]
Phase 3 trial evaluating oxaliplatin with S-1 (SOX) as neoadjuvant chemotherapy for gastric cancer; currently recruiting.
-
FDA approval · 2021-01-14FDA Approved: DOCETAXEL — Original Application (Hikma Pharmaceuticals USA Inc.)
FDA approves Hikma Pharmaceuticals USA Inc.'s original application for generic docetaxel. Docetaxel is a chemotherapy agent used to treat mu…
-
CLINICAL_TRIALS trial_result · 2021-01-05Clinical Trial Update: Efficacy and Safety of S-1 Plus Oxaliplatin in First-line Treatment of Ederly Patients With Advanced Gastric Cancer [Phase 2]
Phase 2 clinical trial assessing efficacy and safety of S-1 plus oxaliplatin as first-line treatment in elderly patients with advanced gastr…
-
CLINICAL_TRIALS trial_result · 2020-12-30Clinical Trial Update: EGFR Monoclonal Antibody for Advanced Gastric Cancer [Phase 2]
Phase 2 clinical trial update evaluating an EGFR-targeting monoclonal antibody for advanced gastric cancer.
-
CLINICAL_TRIALS trial_result · 2020-12-21Clinical Trial Update: Neoadjuvant Chemotherapy Plus Surgery Versus Surgery First For Elderly Gastric Cancer Patients [Phase 2, Phase 3]
A clinical trial comparing neoadjuvant chemotherapy plus surgery versus surgery first in elderly gastric cancer patients, currently not yet …
-
CLINICAL_TRIALS trial_result · 2020-12-10Clinical Trial Update: Phase II Trial of AUY922 vs. Comparators in Advanced Gastric Cancer [Phase 2]
Phase II trial assessing AUY922 versus comparators in advanced gastric cancer and gastro-esophageal junction cancer has completed.
-
CLINICAL_TRIALS trial_result · 2020-12-09Clinical Trial Update: The Clinical Research of Mesylate Apatinib Combined With Docetaxel and S-1 as the First-line Treatment of Metastatic Gastric Cancer [Phase 2]
A phase 2 clinical trial evaluating mesylate apatinib combined with docetaxel and S-1 as first-line therapy for metastatic gastric cancer.
-
CLINICAL_TRIALS trial_result · 2020-11-30Clinical Trial Update: Oxaliplatin/Irinotecan/Bevacizumab Followed by Docetaxel/Bevacizumab in Inoperable Locally Advanced or Metastatic Gastric Cancer Patients [Phase 2]
Phase 2 trial evaluating a sequencing regimen of oxaliplatin/irinotecan/bevacizumab followed by docetaxel/bevacizumab in unresectable locall…